Vulvovaginal Atrophy
52
3
4
38
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
2 terminated out of 52 trials
95.0%
+8.5% vs benchmark
23%
12 trials in Phase 3/4
26%
10 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (52)
Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors
GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients
Validation of the DIVA (Day to Day Impact of Vaginal Aging) Questionnaire for Portuguese Women
Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM
Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness
Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
Effects of Visnadin, Ethyl Ximeninate, Coleus Barbatus and Millet in Emulgel on Sexual Function in Postmenopausal Women
Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
A Comparison of Hyaluronic Acid and Estradiol Treatment in Vulvovaginal Atrophy.
Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.
Multi-polar RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
Multi-polar RF and PEMF for Treatment of Symptoms Associated With Vulvovaginal Atrophy
Efficacy and Safety of Hyaluronic Acid Injection on Symptoms of Vulvovaginal Atrophy in Postmenopausal Women
Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy
Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women
Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy